Acquiring Company
Labcorp
Acquired Company
Myriad Genetics
BurlingtonSalt Lake CityBiotechnologyHealth CareMedicalHealth DiagnosticsBiotechnologyHealth CareMedicalDescription
Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has closed its acquisition of select operating assets and intellectual property (IP) from Myriad Genetics’ autoimmune business unit, including the Vectra® rheumatoid arthritis (RA) assay.
Quick answer
Labcorp is acquiring Myriad Genetics, announced September 13, 2021. Labcorp is based in Burlington, North Carolina, United States.
- How much did Labcorp pay for Myriad Genetics?
- The deal value was not disclosed.
- What does Labcorp do?
- Labcorp is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions.
- Where are Labcorp and Myriad Genetics based?
- Labcorp is based in Burlington, North Carolina, United States. Myriad Genetics is based in Salt Lake City, Utah, United States.
- Who are the decision-makers at Labcorp?
- Fundz holds 1 contact at Labcorp. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Medical and Health Diagnostics
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Labcorp Completes Acquisition Of Myriad Autoimmune’S Vectra Testing Business (September 13, 2021)
- India: Adani Green Energy Completes The Acquisition Of The 5 Gw Renewable Portfolio Of Sb Energy India (October 4, 2021)
- Well Health Completes Majority Stake Acquisition Of Wisp, A Rapidly Growing Digital Health Leader Specializing In Women'S Health (October 1, 2021)
- Strongbridge Biopharma Plc Announces Court Hearing Date To Approve Proposed Acquisition By Xeris Pharmaceuticals, Inc. (September 23, 2021)
- Slate Grocery Reit Completes Us$390 Million Grocery-Anchored Portfolio Acquisition And Amendment Of Management Agreement, $390M (September 22, 2021)
- Pender Growth Fund And Pender Private Investments Announce Proposed Acquisition Of A Portfolio Company (September 9, 2021)
Who to call at Labcorp, and when
When Labcorp changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Labcorp raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Labcorp, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Labcorp. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Labcorp makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Myriad Genetics?
Myriad Genetics was acquired by Labcorp, based in Burlington. The deal was reported on September 13, 2021. Labcorp is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. Labcorp is publicly traded (LH) and operates in Biotechnology.
When did Labcorp acquire Myriad Genetics?
Labcorp's acquisition of Myriad Genetics was reported on September 13, 2021. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Myriad Genetics do?
Myriad Genetics is a leading molecular diagnostic testing and precision medicine company dedicated to advancing health and well-being for all. It is publicly traded (MYGN), operating in Biotechnology, and is based in Salt Lake City.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.